Health.Zone Web Search

Search results

  1. Results from the Health.Zone Content Network
  2. Danaher Corporation - Wikipedia

    en.wikipedia.org/wiki/Danaher_Corporation

    History Early years. The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales, and in 1984, the company adopted the name Danaher and ...

  3. Dimethylglycine is an essential amino acid, which means that the body cannot make this chemical on its own. It must be consumed in the diet. It is found in grains and meats and can also be taken ...

  4. DMG-PEG 2000 - Wikipedia

    en.wikipedia.org/wiki/DMG-PEG_2000

    DMG-PEG 2000. Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). DMG-PEG 2000 is a synthetic lipid formed by the PEGylation of myristoyl diglyceride. It is used to manufacture lipid nanoparticles that are used in mRNA vaccines, [1] and in particular forms part of the drug delivery ...

  5. Pfizer agrees to settle over 10,000 Zantac lawsuits ... - AOL

    www.aol.com/news/pfizer-agrees-settle-over-10...

    May 8, 2024 at 7:28 AM. (Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on ...

  6. Hikma Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Hikma_Pharmaceuticals

    Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

  7. FDA Approves New Drug for Macular Degeneration - Healthline

    www.healthline.com/health-news/fda-approves-new...

    The Food and Drug Administration (FDA) has approved a new drug for treating two conditions that cause vision loss. The drug Vabysmo (faricimab-svoa) treats wet age-related macular degeneration ...

  8. Is Madrigal Pharmaceuticals Stock a Buy? - AOL

    www.aol.com/madrigal-pharmaceuticals-stock-buy...

    May 21, 2024 at 9:45 AM. Madrigal Pharmaceuticals ' (NASDAQ: MDGL) shares are down by 27% over the past year, while the S&P 500 is up by 26%. However, this poor performance hardly reflects the ...

  9. Assertio Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Assertio_Therapeutics

    Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. [3] It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. [4] Depomed was founded in 1995 and is headquartered in Newark, California. [5] It is a publicly traded company on NASDAQ, with several ...